TABLE 4.

Clinicopathologic features of previously reported intracranial mesenchymal tumors with FET‐CREB fusions

Age	Sex	Location	Fusion	Diagnosis	Adjuvant XRT or chemotherapy	Outcome	Length of follow‐up	Reference
25	M	Occipital	EWSR1‐ATF1	AFH	Unknown	Unknown	None	Dunham 2008
15	F	Not specified	EWSR1‐CREM	IMMT	None	Alive, disease‐free	17 months	Kao 2017
23	F	Occipital	EWSR1‐CREB1	IMMT	Unknown	Unknown	None	Kao 2017
20	M	Frontal	EWSR1‐CREB1	IMMT	Unknown	Unknown	None	Kao 2017
12	M	Frontal	EWSR1‐ATF1	IMMT	Unknown	Unknown	None	Kao 2017
19	M	CP angle	EWSR1‐CREM	AFH	XRT +chemo	Alive w/ local recurrence at 10 years	120 months	Gareton 2018
17	F	Frontal	EWSR1‐ATF1	IMMT	None	Alive w/ local recurrences at 20 months and 7 years	90 months	Sciot 2018
18	M	Frontal	EWSR1‐CREM	IMMT	None	Alive, disease‐free	12 months	Bale 2018
17	M	CP angle	EWSR1‐CREB1	IMMT	None	Alive w/ local recurrences at 8 months and 20 months	36 months	Velz 2018
13	F	Frontal	EWSR1‐ATF1	AFH	None	Alive w/ local recurrence at 5 years	72 months	Konstantinidis 2019
12	F	Frontal	EWSR1‐CREM	AFH	None	Alive w/ local recurrence at 28 months	28 months	Konstantinidis 2019
58	F	Parietal	EWSR1‐CREB1	myxoid AFH	None	Alive w/ residual disease	3 months	Ghanbari 2019
9	M	Frontal	EWSR1‐CREM	IMMT	None	Alive w/ local recurrence at 6 months	6 months	White 2019
53	F	Third ventricle	EWSR1‐CREB1	IMMT	XRT	Alive, disease‐free	3 months	Komastu 2020
67	M	Temporal	EWSR1‐ATF1	IMMT	Unknown	Unknown	None	Ballester 2020
50	F	Frontal	EWSR1‐ATF1	AFH	Unknown	Unknown	None	Vizcaino 2020
48	F	Lateral ventricle	EWSR1‐ATF1	IMMT	None	Alive w/ local recurrence at 4 months	17 months	Ward 2020
58	F	Lateral ventricle	EWSR1‐CREB1	IMMT	None	Alive, disease‐free	6 months	Aguiar 2020